Cutaneous Squamous Cell Carcinoma Treatment Market
- 2026 年市場規模
- USD 15,800 Mn
- 2033 年預估規模
- USD 25,800 Mn
- 年複合成長率 CAGR
- 7.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cutaneous Squamous Cell Carcinoma Treatment Market, By Treatment (Surgical (Mohs Micrographic Surgery (MMS), Electrodessication or Curettage), Non-surgical (Chemotherapy, Topical Immune Response Modifiers, Radiotherapy, and Systemic Chemotherapy)), By Application (Hospitals, Cancer Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer grouped in the class of keratinocyte cancer, or non-melanoma skin cancer. It is derived from cells within the epidermis that make keratin, the protein which makes up skin, hair, and nails. Cutaneous squamous cell carcinoma (cSCC) is an invasive disease, referring to cancer cells that have grown beyond the epidermis. Ultraviolet (UV) solar radiation is the primary risk factor in the development of cutaneous squamous cell carcinoma.
Market Dynamics
Rising incidence of cutaneous squamous cell carcinoma (cSCC) is expected to drive cutaneous squamous-cell carcinoma treatment market growth. For instance, according to the National Center for Biotechnology Information (NCBI), an article published in August 2020, stated that squamous cell carcinoma is the second most common form of skin cancer in the U.S followed by basal cell carcinoma. It also reports that over one million squamous cell carcinoma cases are diagnosed in the U.S. each year.
However, lack of standardization in the guidelines for cutaneous squamous cell carcinoma (cSCC) creates a challenge for physicians to execute the treatment, and this is expected to hinder the market growth. For instance, according to the National Center for Biotechnology Information (NCBI), an article published in August 2020, stated that physician's challenge lies in properly assessing a patient's risk for aggressive disease based on tumor or host characteristics.
Key features of the study
• This report provides in-depth analysis of the global cutaneous squamous-cell carcinoma treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cutaneous squamous-cell carcinoma treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A., Cadila Healthcare Limited, Cipla Limited, Castle Biosciences, Regeneron Pharmaceuticals, Inc., Merck & Co., Inc., Vidac Pharma, LEO Pharma A/S, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme, and Amgen Inc. among others
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global cutaneous squamous-cell carcinoma treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cutaneous squamous-cell carcinoma treatment market.
Cutaneous Squamous Cell Carcinoma Treatment Market Segmentation
• By Treatment Insights
o Surgical
Moh’s Micrographic Surgery (MMS)
Electrodessication or Curettage
o Non-surgical
Chemotherapy
Topical Immune Response Modifiers
Radiotherapy
Systemic Chemotherapy
• By Application Insights
o Hospitals
o Cancer Institutes
o Ambulatory Surgical Centers
o Others
• By Region Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players in the Cutaneous Squamous Cell Carcinoma Treatment Market
o Eli Lilly and Company
o Sanofi S.A.
o Cadila Healthcare Limited
o Cipla Limited
o Castle Biosciences
o Regeneron Pharmaceuticals, Inc
o Merck & Co., Inc
o Vidac Pharma
o LEO Pharma A/S
o Merck Sharp & Dohme
o Amgen Inc
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Treatment
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o Reimbursement Scenario
o Epidemiology
o Pest Analysis
o Regulatory Scenario
o New Product Launches
o Collaborations and Agreements
o Market Trends
4. Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Treatment, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Surgical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Moh’s Micrographic Surgery (MMS)
o Electrodessication or Curettage
o Non-surgical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Chemotherapy
o Topical Immune Response Modifiers
o Radiotherapy
o Systemic Chemotherapy
5. Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Application, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Cancer Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
6. Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Region, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Treatment, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Mn)
Market Size and Forecast, By Country/Region, 2021 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cadila Healthcare Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cipla Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Castle Biosciences
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Regeneron Pharmaceuticals, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & Co., Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Vidac Pharma
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
LEO Pharma A/S
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Regeneron Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck Sharp & Dohme
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amgen Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們